The global demand for Intraoperative Radiation Therapy Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
A radiation therapy that requires precise and large dose delivery of radiation during surgery in the operating room is known as intraoperative radiation therapy (IORT). In this therapy, therapeutic levels of radiation are delivered to the tumor bed. This therapy can be used in early-stage cancers such as breast cancers and prostate. IORT is quite useful in the multidisciplinary management of solid tumors. Electron beams, orthovoltage x-rays, high dose rate brachytherapy are some methods that are used to deliver intraoperative radiation therapy. This therapy (IORT) allows re-irradiation, unlike EBRT where further irradiation may not be possible. Intraoperative radiation therapy may be used alone as well as in combination with EBRT.
Market Dynamics
The growing prevalence of cancer and advantages offered by intraoperative radiation therapy is the key driver for the growth of this market. IORT has several advantages over conventional radiotherapy like high precision, limited treatment time, etc. are the driving factors for the intraoperative radiation therapy market. Also, the increased application of intraoperative radiation therapy for cancer treatment and high investment in the medical field are the major drivers for the growth of the IORT market. Some factors like risk of radiation exposure, unavailability of trained personnel, etc may restraint the growth of the IORT market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of intraoperative radiation therapy. The growth and trends of intraoperative radiation therapy industry provide a holistic approach to this study.
Market Segmentation
This section of the intraoperative radiation therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product and Service
- Products (Systems/Accelerators, Applicators & Afterloaders, Treatment Planning Systems, Accessories)
- Services
By Technology
- Electron IORT
- Intraoperative Brachytherapy
By Application
- Breast Cancer
- Brain Tumor
- Gastrointestinal Cancer
- Head & Neck Cancer
- Colorectal Cancer
- Endometrial & Cervical Cancer
- Lung Cancer
- Other
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Intraoperative Radiation Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Intraoperative Radiation Therapy Market Share by Region (Representative Graph)
Know more about this report: Download free sample
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the intraoperative radiation therapy market include Carl Zeiss AG, Ariane Medical Systems Ltd, Eckert & Ziegler, Elekta AB, GMV, Elekta AB (pub), iCAD Inc., Xoft, IntraOp Medical, Inc., Sordina Iort Technologies, Varian Medical Systems, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.